Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
16.04.2026 15:53:27
|
Abbott Laboratories Stock Drops 4% Over Decline In Q1 Earnings
(RTTNews) - Shares of Abbott Laboratories (ABT) are falling about 4 percent on Thursday morning trading after the company announced a decline in first-quarter earnings to $1.07 billion, or $0.61 per share, from last year's $1.32 billion, or $0.76 per share.
The company's stock is currently trading at $97.21, down 4.21 percent or $4.27, over the previous close of $101.56 on the New York Stock Exchange. It has traded between $96.82 and $139.06 in the past one year.
However, the company's revenue for the period rose to $11.16 billion from $10.35 billion in the previous year. Additionally, the company stated that it now projects full-year 2026 adjusted EPS of $5.38 to $5.58.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratories
Analysen zu Abbott Laboratories
Aktien in diesem Artikel
| Abbott Laboratories | 95,98 | 0,97% |
|